GB0125443D0 - Organic Compounds - Google Patents

Organic Compounds

Info

Publication number
GB0125443D0
GB0125443D0 GBGB0125443.2A GB0125443A GB0125443D0 GB 0125443 D0 GB0125443 D0 GB 0125443D0 GB 0125443 A GB0125443 A GB 0125443A GB 0125443 D0 GB0125443 D0 GB 0125443D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0125443.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0125443.2A priority Critical patent/GB0125443D0/en
Priority claimed from GB0127341A external-priority patent/GB0127341D0/en
Publication of GB0125443D0 publication Critical patent/GB0125443D0/en
Priority to US10/492,439 priority patent/US7259170B2/en
Priority to IL16097302A priority patent/IL160973A0/xx
Priority to NZ532412A priority patent/NZ532412A/en
Priority to AU2002346859A priority patent/AU2002346859C1/en
Priority to HU0402108A priority patent/HUP0402108A3/hu
Priority to PCT/EP2002/011799 priority patent/WO2003035068A1/en
Priority to EP02782975A priority patent/EP1439838A1/en
Priority to PL02368533A priority patent/PL368533A1/xx
Priority to CNB028211588A priority patent/CN1307993C/zh
Priority to KR1020097021354A priority patent/KR20090114483A/ko
Priority to KR1020047005958A priority patent/KR100978971B1/ko
Priority to RU2004116067/15A priority patent/RU2321402C2/ru
Priority to CA2458690A priority patent/CA2458690C/en
Priority to JP2003537635A priority patent/JP2005509634A/ja
Priority to MXPA04003738A priority patent/MXPA04003738A/es
Priority to BR0213463-2A priority patent/BR0213463A/pt
Priority to ZA200401711A priority patent/ZA200401711B/en
Priority to EC2004005086A priority patent/ECSP045086A/es
Priority to NO20042074A priority patent/NO20042074L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GBGB0125443.2A 2001-10-23 2001-10-23 Organic Compounds Ceased GB0125443D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GBGB0125443.2A GB0125443D0 (en) 2001-10-23 2001-10-23 Organic Compounds
MXPA04003738A MXPA04003738A (es) 2001-10-23 2002-10-22 Composiciones farmaceuticas que contienen macrolidos.
BR0213463-2A BR0213463A (pt) 2001-10-23 2002-10-22 Composições farmacêuticas contendo macrólidos
CNB028211588A CN1307993C (zh) 2001-10-23 2002-10-22 含有大环内酯的药物组合物
KR1020097021354A KR20090114483A (ko) 2001-10-23 2002-10-22 마크롤리드 함유 제약 조성물
NZ532412A NZ532412A (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
AU2002346859A AU2002346859C1 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
HU0402108A HUP0402108A3 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
PCT/EP2002/011799 WO2003035068A1 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
EP02782975A EP1439838A1 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
PL02368533A PL368533A1 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
US10/492,439 US7259170B2 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
IL16097302A IL160973A0 (en) 2001-10-23 2002-10-22 Macrolides containing pharmaceutical compositions
KR1020047005958A KR100978971B1 (ko) 2001-10-23 2002-10-22 마크롤리드 함유 제약 조성물
RU2004116067/15A RU2321402C2 (ru) 2001-10-23 2002-10-22 Фармацевтические композиции, содержащие макролиды
CA2458690A CA2458690C (en) 2001-10-23 2002-10-22 Pharmaceutical compositions comprising an ascomycin derivative
JP2003537635A JP2005509634A (ja) 2001-10-23 2002-10-22 マクロライドを含む医薬組成物
ZA200401711A ZA200401711B (en) 2001-10-23 2004-03-02 Macrolides containing pharmaceutical compositions.
EC2004005086A ECSP045086A (es) 2001-10-23 2004-04-23 Composiciones farmaceuticas que contienen macrolidos
NO20042074A NO20042074L (no) 2001-10-23 2004-05-19 Makrolider inneholdende farmasoytiske sammensetninger

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0125443.2A GB0125443D0 (en) 2001-10-23 2001-10-23 Organic Compounds
GB0127341A GB0127341D0 (en) 2001-11-14 2001-11-14 Organic compounds

Publications (1)

Publication Number Publication Date
GB0125443D0 true GB0125443D0 (en) 2001-12-12

Family

ID=26246689

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0125443.2A Ceased GB0125443D0 (en) 2001-10-23 2001-10-23 Organic Compounds

Country Status (19)

Country Link
US (1) US7259170B2 (cg-RX-API-DMAC10.html)
EP (1) EP1439838A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005509634A (cg-RX-API-DMAC10.html)
KR (2) KR20090114483A (cg-RX-API-DMAC10.html)
CN (1) CN1307993C (cg-RX-API-DMAC10.html)
AU (1) AU2002346859C1 (cg-RX-API-DMAC10.html)
BR (1) BR0213463A (cg-RX-API-DMAC10.html)
CA (1) CA2458690C (cg-RX-API-DMAC10.html)
EC (1) ECSP045086A (cg-RX-API-DMAC10.html)
GB (1) GB0125443D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0402108A3 (cg-RX-API-DMAC10.html)
IL (1) IL160973A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA04003738A (cg-RX-API-DMAC10.html)
NO (1) NO20042074L (cg-RX-API-DMAC10.html)
NZ (1) NZ532412A (cg-RX-API-DMAC10.html)
PL (1) PL368533A1 (cg-RX-API-DMAC10.html)
RU (1) RU2321402C2 (cg-RX-API-DMAC10.html)
WO (1) WO2003035068A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200401711B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005512946A (ja) * 2001-05-09 2005-05-12 ノバルティス アクチエンゲゼルシャフト 選択的免疫調節法
MXPA04006709A (es) 2002-01-11 2004-10-04 Sankyo Co Derivados de aminoalcohol o derivados de acido fosfonico y composiciones farmaceuticas que los contienen.
GB0307867D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
KR20110136901A (ko) 2004-02-24 2011-12-21 상꾜 가부시키가이샤 아미노 알코올 화합물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68921934T2 (de) 1988-06-29 1995-10-19 Merck & Co Inc Immunsuppressives Agens.
ATE126803T1 (de) * 1989-11-09 1995-09-15 Sandoz Ag Heteroatome enthaltende tricyclische verbindungen.
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
GB2252041A (en) * 1991-01-23 1992-07-29 Fujisawa Pharmaceutical Co Use of macrolide compounds in treatment of autoimmune myocarditis
AU664178B2 (en) * 1991-03-19 1995-11-09 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5247076A (en) * 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
GB9203636D0 (en) * 1992-02-19 1992-04-08 Lucas Ind Plc Fuel pumping apparatus
KR0155015B1 (ko) * 1992-10-21 1998-12-01 고우야 마사시 2-아미노-1,3-프로판디올 화합물 및 면역 억제제
WO1994021642A1 (en) 1993-03-17 1994-09-29 Abbott Laboratories Macrocyclic amide and urea immunomodulators
US5590460A (en) * 1994-07-19 1997-01-07 Tessera, Inc. Method of making multilayer circuit
DE69524962T4 (de) 1994-08-22 2003-08-28 Mitsubishi Pharma Corp., Osaka Benzolderivate und deren medizinische verwendung
GB9521322D0 (en) 1995-10-17 1995-12-20 Sandoz Ltd Organic compounds
JPH11209277A (ja) 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
GB9624038D0 (en) 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
ES2240868T3 (es) * 1997-04-04 2005-10-16 Mitsubishi Pharma Corporation Compuesto de 2-aminopropano -1,3-diol, su uso farmaceutico e intermedios en su sintesis.
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
JP4627356B2 (ja) * 1999-06-30 2011-02-09 昭 松森 ウイルス性心筋炎の予防または治療薬剤
GB0003932D0 (en) 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
JP2004523275A (ja) 2000-12-22 2004-08-05 アバンテク バスキュラー コーポレーション 治療能力のある薬剤の送達

Also Published As

Publication number Publication date
MXPA04003738A (es) 2004-07-23
RU2321402C2 (ru) 2008-04-10
AU2002346859B2 (en) 2006-03-02
KR20090114483A (ko) 2009-11-03
CN1575173A (zh) 2005-02-02
HUP0402108A2 (hu) 2005-02-28
WO2003035068A1 (en) 2003-05-01
CN1307993C (zh) 2007-04-04
ECSP045086A (es) 2004-06-28
US7259170B2 (en) 2007-08-21
KR20040052250A (ko) 2004-06-22
CA2458690C (en) 2011-01-25
KR100978971B1 (ko) 2010-08-30
NZ532412A (en) 2006-01-27
AU2002346859C1 (en) 2008-07-10
PL368533A1 (en) 2005-04-04
ZA200401711B (en) 2004-10-21
CA2458690A1 (en) 2003-05-01
RU2004116067A (ru) 2005-04-20
NO20042074L (no) 2004-05-19
IL160973A0 (en) 2004-08-31
EP1439838A1 (en) 2004-07-28
HUP0402108A3 (en) 2008-02-28
BR0213463A (pt) 2004-11-09
US20040192716A1 (en) 2004-09-30
JP2005509634A (ja) 2005-04-14

Similar Documents

Publication Publication Date Title
GB0108876D0 (en) Organic Compounds
GB0103389D0 (en) Organic compounds
GB0108606D0 (en) Organic compounds
GB0108337D0 (en) Organic compounds
GB0103303D0 (en) Organic compounds
GB0108087D0 (en) Organic compounds
GB0107368D0 (en) Organic compounds
GB0103258D0 (en) Organic compounds
GB0101598D0 (en) Organic compounds
GB0107365D0 (en) Organic compounds
GB0102841D0 (en) Organic compounds
GB0120690D0 (en) Organic compounds
GB0107506D0 (en) Organic compounds
GB0102948D0 (en) Organic compounds
GB0103047D0 (en) Organic Compounds
GB0102093D0 (en) Organic Compounds
GB0108089D0 (en) Organic compounds
GB0102269D0 (en) Organic compounds
GB0107508D0 (en) Organic compounds
GB0104438D0 (en) Organic compounds
GB0108091D0 (en) Organic compounds
GB0102380D0 (en) Organic compounds
GB0106652D0 (en) Organic compounds
GB0108352D0 (en) Organic compounds
GB0107505D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)